Cancer stem cells

Publications

Neradil, J., Veselska, R. Nestin as a marker of cancer stem cells. Cancer Sci 2015;806(7):803-811. (IF2014: 3,523)

Holčáková, J., Nekulová, M., Orzol, P., Vojtěšek, B. Mechanizmy lékové rezistence a nádorové kmenové buňky.Klin Onkol 2014;27(Suppl1):S34–S41. (Bez IF)

Škoda, J., Neradil, J., Veselská, R. Funkční testy pro detekci nádorových kmenových buněk.Klin Onkol 2014;27(Suppl1):S42–S47. (Bez IF)

Liu, Y., Nenutil, R., Appleyard, M.V., Murray, K., Boylan, M., Thompson, A.M., Coates, P.J. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer 2014;110(8):2063-2071. (IF2012: 5,082)

Veselska, R., Skoda, J., Neradil, J. Detection of cancer stem cell markers in sarcomas. Klin Onkol 2012; 25(Suppl 2): 2S16–2S20. (bez IF)

Nekulova, M., Holcakova, J., Coates, P., Vojtesek, B. The role of p63 in cancer, stem cells and cancer stem cells.Cell Mol Biol Lett 2011;16(2):296-327. (IF2011: 1,505)



  • Mgr. Jitka Holčáková, Ph.D.

    senior researcher

    associations between putative cancer stem cell markers and resistance to conventional therapies, with the ultimate aim of identifying surrogate markers of therapy resistant cell populations in primary tumors and finding:

    1. the differences among pathways connected with recognition, reparation and answers to DNA damage in cancer-initiating stem cells

    2. the role of protein delNp63 in epithelial cancer stem cells maintaining and its effect on answers of cancer stem cells to therapy

    3. the possibility of cancer stem cells to predict the impact of cancer treatment

  • Philip John Coates, Ph.D.

    senior researcher

Molecular oncology for 21st century

Log In

Log In